CRISPR-Cas9 edits genes by harnessing a programmable molecular scissors and the cell’s own DNA repair machinery. Jennifer Doudna, University of California, Berkeley, and Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, described how a bacterial immune system component can be repurposed to target specific DNA sequences. The system’s precision comes from a short RNA sequence that directs the enzyme to a matching DNA site, where the enzyme cuts both strands. Cellular repair of that cut determines the final genetic change.
How the molecular components work
At the core is the Cas9 protein, an RNA-guided endonuclease that binds to DNA and makes a double-strand break at a defined location. Target specificity comes from a guide RNA that pairs with the complementary DNA sequence. Early work separated this guide into CRISPR RNA and trans-activating CRISPR RNA; researchers later engineered a single-guide RNA to simplify targeting. A critical requirement for Cas9 binding is the protospacer adjacent motif or PAM, a short DNA motif next to the target sequence that Cas9 recognizes. For the widely used Streptococcus pyogenes Cas9 the PAM is NGG, which constrains where edits can be introduced. Feng Zhang, Broad Institute of MIT and Harvard, played a central role in adapting CRISPR-Cas9 for use in mammalian cells, enabling genome editing across many organisms.
Cellular repair pathways and editing outcomes
Once Cas9 creates a double-strand break, the cell repairs it using endogenous pathways that determine the editing outcome. Non-homologous end joining NHEJ often rejoins the broken ends imprecisely, causing small insertions or deletions that can disrupt a gene. Homology-directed repair HDR can copy a desired sequence from a supplied DNA template, enabling precise replacement or insertion. HDR is efficient only in certain cell types and cell cycle phases, so achieving precise edits in adult tissues remains a technical challenge. To reduce unwanted effects, researchers have developed high-fidelity Cas9 variants and alternative strategies such as paired nickases that cut only one DNA strand each.
Advances, risks, and societal context
Beyond cutting, new approaches expand what can be edited without making double-strand breaks. David Liu, Harvard University and the Broad Institute, developed base editing and prime editing to directly convert one DNA base to another or write new sequences with fewer risks of large-scale damage. These innovations lower some technical barriers but do not remove ethical and ecological concerns. Gene drives that bias inheritance have been proposed to control disease vectors, and Kevin Esvelt, Massachusetts Institute of Technology, has emphasized community engagement and ecological caution before any release into wild populations. Off-target edits, immune responses to Cas9, and unequal access to therapies raise additional consequences for patients, communities, and territories where interventions might be deployed. Regulatory frameworks and culturally informed consent processes are essential to balance potential public health benefits against irreversible environmental or social impacts.